Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ORMP.TA
- Price
- 7.54
- Stock movement down
- -8.20 (-1.16%)
- Company name
- Exchange
- (TA ,
- Currency
- ILA )
- Sector
- Healthcare >Biotechnology
- Market cap
- 28.71B
- Ent value
- -
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- 8084.90%
- 3 year return
- 189.78%
- 5 year return
- -10.12%
- 10 year return
- -
Last updated: 2025-09-17
DIVIDENDS
ORMP.TA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 707.30 |
| Daily high | 707.30 |
| Daily low | 700.00 |
| Daily Volume | 7K |
| All-time high | 3365.00 |
| 1y analyst estimate | - |
| Beta | - |
| EPS (TTM) | - |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 6 Nov 2025 |
Downside potential
Loading...
Downside potential data
| ORMP.TA | S&P500 | |
| Current price drop from All-time high | -79.19% | -1.06% |
| Highest price drop | -99.81% | -56.47% |
| Date of highest drop | 29 Jan 2023 | 9 Mar 2009 |
| Avg drop from high | -79.50% | -10.99% |
| Avg time to new high | 608 days | 12 days |
| Max time to new high | 1810 days | 1805 days |
COMPANY DETAILS
Marketcap
28.71B
Marketcap category
Large-cap
Description
Employees
Investor relations
-
SEC filings
CEO
Country
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
The truth is that if you invest for long enough, you're going to end up with some losing stocks. But the long term...
October 28, 2025
Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ("Oramed" or the "Company" or "we"), a clinical-stage pharmaceutical company, today issued a Letter to Shareholders from its President and Chief...
October 23, 2025
PALO ALTO, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and co...
October 1, 2025
NEW YORK (AP) — Oramed Pharmaceuticals Inc. ORMP) on Thursday reported net income of $13.3 million in its second quarter. On a per-share basis, the New York-based company said it had profit of 31 cent...
August 14, 2025
By M. Marin NASDAQ:ORMP READ THE FULL ORMP RESEARCH REPORT Company maintains substantial liquidity Oramed Pharmaceuticals (NASDAQ:ORMP) had cash of $74.5 million at the end of March 2025, up from $54....
July 28, 2025
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
June 27, 2025
NEW YORK (AP) — Oramed Pharmaceuticals Inc. ORMP) on Thursday reported a loss of $7.6 million in its first quarter. On a per-share basis, the New York-based company said it had a loss of 19 cents.
May 15, 2025
Investment comes at a pivotal moment for Alpha Tau, which is experiencing remarkable growth on multiple fronts, with four active U.S. trial approvals, expansion into multiple internal organ applicatio...
April 28, 2025
Oramed Pharmaceuticals Inc. ("Oramed" or the "Company"), (Nasdaq: ORMP) (TASE: ORMP), a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection,...
April 28, 2025
By M. Marin NASDAQ:ORMP READ THE FULL ORMP RESEARCH REPORT Planning Spin-off / IPO of JV Company Oramed Pharmaceuticals (NASDAQ:ORMP) formed a JV with Hefei Tianhui Biotech (HTIT), OraTech Pharmaceuti...
April 3, 2025
Next page